Prandial 0.3 MD Tablet
Marketer
Cipla Ltd
Salt Composition
Voglibose (0.3mg)
Overview Prandial 0.3 MD Tablet
Postprandial 0.3 MD Tablet is a medication indicated for the management of type 2 diabetes. It aids in regulating elevated post-meal blood glucose. This medication is prescribed when dietary modifications and other comparable therapies prove insufficient in controlling hyperglycemia. Administer Postprandial 0.3 MD Tablet immediately prior to each meal. Dosage frequency is determined by your physician to optimize glycemic control. Discontinue use only under medical supervision; abrupt cessation may elevate blood glucose, potentially leading to serious complications such as nephropathy and vision impairment. This treatment forms part of a comprehensive program encompassing a balanced diet, regular physical activity, and weight management as directed by your doctor. Regular blood glucose monitoring is essential. Commonly reported adverse effects include abdominal distension, abdominal discomfort, anorexia, constipation, and diarrhea. Report persistent or bothersome side effects to your doctor. While this medication alone does not cause hypoglycemia, concomitant use with other antidiabetic agents (especially insulin or sulfonylureas) increases this risk. Glucose should be administered to counteract hypoglycemic episodes; sucrose is ineffective. Inform your physician of any hepatic or renal dysfunction before commencing therapy. This medication is contraindicated in patients with gastrointestinal ulceration or inflammation (e.g., ulcerative colitis, Crohn's disease). Pregnant or lactating individuals should seek medical counsel prior to use. Always disclose all medications you are currently taking to ensure safety. Limit alcohol consumption to minimize the potential for hypoglycemia.
Uses of Prandial 0.3 MD Tablet
Managing type 2 diabetes
Major Benefits of Prandial 0.3 MD Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Avoid handling the tablets with damp hands. Allow the 0.3 MD Prandial Tablet to dissolve in your mouth before swallowing; administer on an empty stomach.
Common Side effects of Prandial 0.3 MD Tablet:
- Skin rash
- Flatulence
- Abdominal pain
- Diarrhea
How to use Prandial 0.3 MD Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Avoid handling the tablets with damp hands. Place the tablet in your mouth, allowing it to dissolve before swallowing. Administer Prandial 0.3 MD Tablet on an empty stomach.
How Prandial 0.3 MD Tablet works:
Taken with meals, the 0.3 MD Prandial Tablet combats elevated blood sugar. Its mechanism involves blocking intestinal enzymes that digest complex carbohydrates, thus moderating postprandial glucose spikes.
SAFETY ADVICE
AlcoholUNSAFE
Avoid alcohol consumption while taking Prandial 0.3 MD Tablet.
PregnancySAFE IF PRESCRIBED
The use of 0.3 mg Prandial tablets during pregnancy is typically deemed safe. Preclinical trials in animals revealed minimal or absent negative impacts on fetal development; nevertheless, data from human studies are scarce.
Breast feedingSAFE IF PRESCRIBED
Using Prandial 0.3 MD Tablet while breastfeeding appears to be safe. Available human data indicates minimal risk to the infant.
DrivingSAFE
Taking a 0.3 mg Prandial tablet generally won't impair your driving ability.
KidneyCAUTION
Individuals with severe kidney impairment should exercise caution when using Prandial 0.3 MD Tablet. Dosage modification may be necessary. Physician consultation is recommended.
LiverCAUTION
Patients with severe hepatic impairment should use Prandial 0.3 MD Tablet cautiously, as dose modification may be necessary. Physician consultation is advised.
What if you forget to take Prandial 0.3 MD Tablet :
Omit any missed Prandial 0.3 MD Tablet dose and resume your regular medication regimen. Avoid taking a double dose.
Facts to Know About Prandial 0.3 MD Tablet
| Label | Value |
|---|---|
| Chemical Category | Valiolamine analog |
| Developing Habits | No. |
| Treatment Category | Diabetes Management |
| Actions | Alpha-glucosidase inhibitors |






